Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001662579-24-000080
Filing Date
2024-09-17
Accepted
2024-09-17 17:12:06
Documents
1
Period of Report
2024-09-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1726607520.html 4  
1 FORM 4 wk-form4_1726607520.xml 4 7106
  Complete submission text file 0001662579-24-000080.txt   8591
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Issuer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM MA 02451
Business Address
Schick Kelly (Reporting) CIK: 0001797388 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39567 | Film No.: 241305292